Cancer patients may benefit from reporting symptoms online in real time

November 29, 2007

NEW YORK, November 29, 2007 - Traditionally, clinicians have relied on information provided by cancer patients during their office visits as the primary means of assessing patients' symptoms and side effects. However, potentially serious consequences could arise if important symptoms go unreported during those visits because they occur between appointments.

A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) finds that even the sickest cancer patients are willing and able to "self-report" symptoms using the Internet, thus supplying key data in real time to their healthcare providers.

Published in the December 1, 2007, issue of the Journal of Clinical Oncology, the study suggests a new direction in cancer care. According to the authors, supplementing traditional office visit discussions with online patient self-reporting can fill important gaps in clinicians' knowledge and in doing so may significantly improve patient safety and quality of care.

"Cancer care has become increasingly complex, causing office visits to become more compressed. This makes it challenging for the clinician to comprehensively assess each patient's symptoms in that brief window of time," said the study's lead author, Ethan Basch, MD, a medical oncologist at MSKCC. "Because cancer therapies can be highly toxic, early detection of symptoms and timely treatment is vital. What is exciting to us about online self-reporting is that patients can alert clinicians to crucial symptoms in real time."

The research team developed a Web-based system that patients in the study could access using computers in waiting-room kiosks and at home to communicate their symptoms directly to clinicians. Investigators adapted the National Cancer Institute's standard terminology for tracking patient toxicities in clinical trials and translated it into patient-friendly language. The new terms were uploaded to a secure Web site called Symptom Tracking and Reporting (STAR). Participants used the system to report their cancer- and chemotherapy-related side effects, including pain, fatigue, constipation, diarrhea, nausea, vomiting, shortness of breath, and decreased mobility, as well as their overall quality of life.

From June 2005 through March 2006, 107 lung cancer patients receiving outpatient chemotherapy at MSKCC enrolled in the study. Patients were followed for up to 16 months and 40 visits. Most enrollees were between the ages of 50 and 69, although 28 percent were older than 70. Patients were more likely to use the system if they had prior computer experience; however, age, gender, and cancer stage had no effect on log-in rates.

Researchers found that 100 percent of patients used the waiting room kiosks at some or all of their office visits. An average of 78 percent of participants logged in to the system at any given office visit.

According to the findings, patients were satisfied with the system. Most respondents (98 percent) found STAR easy to use, 90 percent said it was useful, and 77 percent expressed that it improved the quality of their discussions with clinicians.

"Our study suggests that the broader use of patient self-reporting in oncology would be beneficial," said study co-author Mark G. Kris, MD, Chief of the Thoracic Oncology Service at MSKCC. "STAR makes it easier for patients to provide information to their doctors about their symptoms and side effects. The fact that this information can be collected anywhere and immediately stored and shared hastens and expands our research efforts as well."

Optional home access to STAR was also offered to study participants. Home users accessed STAR more frequently than clinic-only users, with an average of 23 online sessions versus nine, respectively. Although 76 percent of patients had home computers, only 15 percent reported from home, possibly due to a lack of regular reminders, and to the perception among participants that self-reported information was not being explicitly addressed by clinicians.

Patients were informed that no clinician would regularly monitor STAR reports between visits, and therefore should contact staff directly if severe of disabling symptoms occurred at home. Nonetheless, an automated "alert" system was integrated so that anytime a patient entered a symptom above a certain level of severity, an on-screen message appeared encouraging the patient to contact a clinician, and an e-mail warning was automatically sent to a designated nurse.

Although the study focused on the patient experience, its results suggest that self-reported data is a potentially valuable resource for clinicians as well. At each follow-up office visit, symptom reports were printed for clinical nurses. It was left to the discretion of patients and clinicians whether and how to incorporate STAR reports into their discussions.

"All of the nurses who participated in the study understood the reports and felt this information was highly useful for clinical decisions, documentation, and discussions," said Ann Culkin, RN, a nurse on the Thoracic Oncology Service at MSKCC and a co-author of the study.

The nurses all noted that they had altered management based on patient-reported information and alerts from STAR, including recommending medication and lifestyle changes and arranging for additional physician consultations.

The authors concluded that online self-reporting is a feasible long-term strategy for monitoring toxicities during chemotherapy, even among very ill patients. However, explicit reminders to log in and clinician feedback on self-reported information are important to maintain patients' continued interest and participation between visits.

"These findings lay the groundwork for future research to assess whether patient self-reporting improves the efficiency and comprehensiveness of toxicity monitoring in clinical trials, and whether this approach can improve the quality of routine cancer care by expediting detection of severe or disabling toxicities," said Dr. Basch. These questions are currently being explored by Dr. Basch and his colleagues in a large randomized study at MSKCC and an NCI-sponsored multicenter trial, with results expected in 2009.
-end-
Funding support for the study was provided in part by the Steps for Breath Fund for Lung Cancer Research and The Society of Memorial Sloan-Kettering Cancer Center.

Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose, and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide.

Memorial Sloan Kettering Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.